Between Bedside and Bench | Published:

The not-so-simple HDL story

A new era for quantifying HDL and cardiovascular risk?

Nature Medicine volume 18, pages 13461347 (2012) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Nat. Med. 18, 1344–1346 (2012).

  2. 2.

    , , , & Cell Metab. 7, 365–375 (2008).

  3. 3.

    et al. Nat. Med. 3, 744–749 (1997).

  4. 4.

    et al. Proc. Natl. Acad. Sci. USA 96, 9322–9327 (1999).

  5. 5.

    et al. Arterioscler. Thromb. Vasc. Biol. 30, 796–801 (2010).

  6. 6.

    et al. N. Engl. J. Med. 364, 127–135 (2011).

  7. 7.

    et al. Clin. Chem. 57, 392–410 (2001).

  8. 8.

    et al. J. Clin. Invest. 117, 746–756 (2007).

  9. 9.

    et al. J. Am. Coll. Cardiol. 60, 508–516 (2012).

  10. 10.

    et al. Circulation 118, 1259–1267 (2008).

Download references

Author information

Affiliations

  1. Jay W. Heinecke is in the Department of Medicine, University of Washington, Seattle, Washington, USA.

    • Jay W Heinecke

Authors

  1. Search for Jay W Heinecke in:

Competing interests

J.W.H. receives research support from Merck, GlaxoSmithKline and Bristol-Myers Squibb.

Corresponding author

Correspondence to Jay W Heinecke.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm.2930

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing